SUVEN PHARMACEUTICALS LTD - Announcement under Regulation 30 (LODR)-Cessation

Suven Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Cessation

Download	< Back
20 Jan 2022
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Para A of Part A of Schedule III to the Listing Regulations, we wish to inform that Dr. Chandrasekhar Srivari (DIN: 00481481) has resigned from the position of the Non-executive Independent Director of the Company with effective from January 19, 2022 due to new appointment as Secretary, Department of Science and Technology, Govt. of India, New Delhi. Further, please find below requisite disclosures as per Regulation 30 read with Para A of Part A of Schedule III to the Listing Regulations as amended from time to time:
View all announcements for Suven Pharmaceuticals Ltd	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us